NAGE

1.8401.60%
OP

Ozan Pamir

CFO & Principal Accounting Officer

Mr. Ozan Pamir is CFO & Principal Accounting Officer of Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) from October 21, 2024. Mr. Ozan Pamir, CFA, served as Chief Financial Officer at 180 Life Sciences Corp. since April 27, 2023 until September 30, 2024. He served as Interim Chief Financial Officer at 180 Life Sciences Corp. since November 27, 2020 until April 27, 2023 and served as its Secretary until September 30, 2024. Mr. Pamir served as the Chief Financial Officer at Global Gaming Technologies Corp. since April 2019 until August 2019. Mr. Pamir is a former investment banker with in-depth capital markets knowledge. Mr. Pamir has advised numerous private and public company leadership teams on M&A initiatives and he was the lead banker on more than 40 financings, where he became an expert at working with complex structures and financial analysis. He is also the Chief Financial Officer and a board member of Unify Pharmaceuticals from August 2019 to July 2021. He served as Chief Financial Officer of Enosi Life Sciences Corp. from May 2020 to April 2021. Mr. Pamir served as the Chief Financial Officer of X2 Games. Mr. Pamir served in various positions with Echelon Wealth Partners, a leading Canadian investment bank, from June 2014 to October 2018, including Investment Banking Analyst (June 2014 ? June 2015), Senior Associate, Investment Banking (June 2015 ? September 2017) and Vice President of Investment Banking (September 2017 ? October 2018), as well as Investment Banking Analyst of OCI Groups from October 2013 to June 2014. Mr. Pamir has an Economics and Finance degree from McGill University and is a CFA Charter holder.

Positions